Unknown

Dataset Information

0

Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis.


ABSTRACT: PURPOSE:Brain metastases of breast cancer contribute significantly to patient morbidity and mortality. We have tested pazopanib, a recently approved antiangiogenic drug that targets VEGFR1, VEGFR2, VEGFR3, PDGFR?, PDGFR?, and c-kit, for prevention of experimental brain metastases and mechanism of action. EXPERIMENTAL DESIGN:In vitro assays included B-Raf enzymatic assays, Western blots, and angiogenesis assays. For in vivo assays, HER2 transfectants of the brain seeking sublines of MDA-MB-231 cells (231-BR-HER2) and MCF7 cells (MCF7-HER2-BR3, derived herein) were injected into the left cardiac ventricle of mice and treated with vehicle or pazopanib beginning on day 3 postinjection. Brain metastases were counted histologically, imaged, and immunostained. RESULTS:Treatment with 100 mg/kg of pazopanib resulted in a 73% decline in large 231-BR-HER2 metastases (P < 0.0001) and a 39% decline in micrometastases (P = 0.004). In vitro, pazopanib was directly antiproliferative to 231-BR-HER2 breast cancer cells and inhibited MEK and ERK activation in vitro despite B-Raf and Ras mutations. Enzymatic assays demonstrated that pazopanib directly inhibited the wild type and exon 11 oncogenic mutant, but not the V600E mutant forms of B-Raf. Activation of the B-Raf targets pERK1/2 and pMEK1/2 was decreased in pazopanib-treated brain metastases whereas blood vessel density was unaltered. In the MCF7-HER2-BR3 experimental brain metastasis model, pazopanib reduced overall brain metastasis volume upon magnetic resonance imaging (MRI) by 55% (P = 0.067), without affecting brain metastasis vascular density. CONCLUSIONS:The data identify a new activity for pazopanib directly on tumor cells as a pan-Raf inhibitor and suggest its potential for prevention of brain metastatic colonization of HER2(+) breast cancer.

SUBMITTER: Gril B 

PROVIDER: S-EPMC3059742 | biostudies-literature | 2011 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis.

Gril Brunilde B   Palmieri Diane D   Qian Yong Y   Smart DeeDee D   Ileva Lilia L   Liewehr David J DJ   Steinberg Seth M SM   Steeg Patricia S PS  

Clinical cancer research : an official journal of the American Association for Cancer Research 20101116 1


<h4>Purpose</h4>Brain metastases of breast cancer contribute significantly to patient morbidity and mortality. We have tested pazopanib, a recently approved antiangiogenic drug that targets VEGFR1, VEGFR2, VEGFR3, PDGFRβ, PDGFRα, and c-kit, for prevention of experimental brain metastases and mechanism of action.<h4>Experimental design</h4>In vitro assays included B-Raf enzymatic assays, Western blots, and angiogenesis assays. For in vivo assays, HER2 transfectants of the brain seeking sublines o  ...[more]

Similar Datasets

| S-EPMC7269144 | biostudies-literature
| S-EPMC10962705 | biostudies-literature
| S-EPMC4809353 | biostudies-literature
| S-EPMC3688013 | biostudies-literature
| S-EPMC7270957 | biostudies-literature
| S-EPMC6742563 | biostudies-literature
| S-EPMC10791565 | biostudies-literature
| S-EPMC5402631 | biostudies-literature
| S-EPMC10248581 | biostudies-literature
| S-EPMC6720990 | biostudies-literature